Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The ...

Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.

Knowable Magazine answers questions about how dangerous bird flu is, where it came from, and what key events paved the way ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

This isn’t just an animal health crisis — it’s a risk to public health. When animals consume foods containing live virus, ...

Researchers have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 ...

As the virus keeps changing, experts worry it could spread more easily to humans. “An H5N1 vaccine made (for an earlier ...

As the U.S. market navigates a turbulent landscape marked by volatile trading sessions and fluctuating economic indicators, investors are closely watching the impact of ongoing tariff developments and ...

USDA under then Secretary Tom Vilsack conditionally approved a vaccine made by Zoetis, containing a killed version of an H5N2 variant designed to work against circulating H5N1 variants.